首页 | 本学科首页   官方微博 | 高级检索  
     

椒梅连理汤抗慢性溃疡性结肠炎的实验研究
引用本文:周春和,高玉华,高社光,王玲玲,宋立峰,申炜,郭兴芳,李志斌,刘娜. 椒梅连理汤抗慢性溃疡性结肠炎的实验研究[J]. 环球中医药, 2012, 5(8): 565-568
作者姓名:周春和  高玉华  高社光  王玲玲  宋立峰  申炜  郭兴芳  李志斌  刘娜
作者单位:1. 河北省邯郸市中医院肛肠科,056001
2. 邯郸市传染病医院
3. 河北省邯郸市中医院老年病科,056001
摘    要:目的 观察椒梅连理汤抗实验性溃疡性结肠炎的作用,探讨其治疗作用可能的免疫学机制.方法 将43只SD大鼠随机分为4组:正常组10只,模型组、柳氮磺胺吡啶组(SASP组)、椒梅连理汤组(中药组)各11只.采用三硝基苯磺酸法制备大鼠溃疡性结肠炎模型,分别予以相应药物1 ml/100 g灌胃,每天1次,连续4周.检测大鼠血清及结肠黏膜中白介素1β(IL-1β)、白介素4(IL-4)、白介素6(IL-6)、肿瘤坏死因子α(TNF-α)的含量.结果 模型组大鼠肠黏膜出现充血、水肿、增生和溃疡,SASP组和中药组较模型组明显好转.与正常组比较,模型组大鼠IL-1β、IL-6、TNF-α明显升高(P<0.05),IL-4明显下降(P<0.05),SASP组、中药组和模型组比较,IL-1β、IL-6、TNF-α降低(P<0.05),IL-4升高(P<0.05).SASP组和中药组之间比较差异无统计学意义(P>0.05).结论 椒梅连理汤能有效对抗实验性溃疡性结肠炎,与SASP相当,通过调节IL-1β、IL-6、TNF-α、IL-4含量可能是其治疗机制之一.

关 键 词:椒梅连理汤  溃疡性结肠炎  白介素-1β  白介素-4  白介素-6  肿瘤坏死因子α  大鼠

Experiments on Jiaomei Lianli Decoction in the treatment of chronic ulcerative colitis
ZHOU Chun- he,GAO Yu-hua. Experiments on Jiaomei Lianli Decoction in the treatment of chronic ulcerative colitis[J]. Global Chinese Medicine, 2012, 5(8): 565-568
Authors:ZHOU Chun- he  GAO Yu-hua
Affiliation:, GAO She-guang, et al( Department of Anorectal Surgery, Traditonal Chinese Medicine Hospital of Handan, Handan 056001, China)
Abstract:Objective To observe the anti-ulcerative colitis effects of Jiaomei Lianli Decoction, and to discuss the possible immunological mechanisms of the treatment effect. Methods 43 SD rats were randomly divided into four groups, normal group ( n = 10 ), model group ( n = 11 ), salicylazosulfapyridine group ( SASP group) ( n = 11 ), Jiaomei Lianli Decoction group ( TCM group) ( n = 11 ). The rat ulcerative colitis model was established by using 2.4.6-trinitrobenzene sulfonic acid (TNBS). Corresponding drugs were respectively administered by gastric infusion to the groups for 1 ml/100 g one day for four weeks. Content of IL-1β, IL-4, IL-6, TNF alpha in serum and colonic mucosa were detected. Results There were congestion, edema, proliferation and ulcers in colonic mucosa of model rat, while the conditionS of SASP group and TCM group were improved obviously. Compared with normal group, contents of IL-1β, IL-6, TNF alpha of model group were increased significantly (P〈0.05), content of IL-4 declined obviously (P 〈 0.05). Compared with model group, contents of IL-1β, IL-6, TNF alpha of SASP group and TCM group declined significantly ( P〈0.05 ), content of IL-4 increased obviously ( P〈0.05 ). There were no significant differences between SASP group and TCM group (P 〉 0.05 ). Conclusion Jiaomei Lianli Decoction demonstrated effective anti-ulcerative colitis by adjusting the content of IL-1β, IL-6, TNF alpha and IL-4, which may be one of the treatment mechanisms, and the effects were similar to SASP.
Keywords:Jiaomei Lianli Decoction  Ulcerative colitis  Interleukin-1β  Interleukin-4  Interleukin-6  Tumor necrosis factor alpha  Rats
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号